Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies. 

Health & Wellness

Fresenius Kabi

Pierluigi Antonelli

Helio Fujita

Arunesh Verma

Rahul Sharma

Sang-Jin Pak

Matthias Tyssen

Eduardo Montanha

Alain Mollard

Ulf Jansson

Marc Crouton

Christian Hauer

Marc-Alexander Mahl

Andreas Duenkel

Leadership Team

Supply Chain and Procurement Team

Operations and Supply Chain

Data and Analytics

Biopharmaceuticals & Pharma

Regional and Country Management

Administration and Coordination

Finance Team

��

Teams at Fresenius Kabi

Leadership Team

Supply Chain and Procurement Team

Operations and Supply Chain

Data and Analytics

Biopharmaceuticals & Pharma

Regional and Country Management

Administration and Coordination

Finance Team

��������

Teams at Fresenius Kabi

Leadership Team

Supply Chain and Procurement Team

Operations and Supply Chain

Data and Analytics

Biopharmaceuticals & Pharma

Regional and Country Management

Administration and Coordination

Finance Team

��